KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $6,326 | +103.6% | 20,000 | +8.2% | 0.01% | +85.7% |
| Q3 2023 | $3,107 | -20.4% | 18,490 | +2.7% | 0.01% | -22.2% |
| Q2 2023 | $3,902 | +20.3% | 18,000 | 0.0% | 0.01% | +12.5% |
| Q1 2023 | $3,244 | -7.1% | 18,000 | 0.0% | 0.01% | -11.1% |
| Q4 2022 | $3,493 | -99.9% | 18,000 | 0.0% | 0.01% | -25.0% |
| Q3 2022 | $4,084,000 | +62.2% | 18,000 | -10.7% | 0.01% | +71.4% |
| Q2 2022 | $2,518,000 | +112.1% | 20,150 | +108.8% | 0.01% | +133.3% |
| Q1 2022 | $1,187,000 | +2.9% | 9,650 | +10.3% | 0.00% | 0.0% |
| Q4 2021 | $1,154,000 | +14.3% | 8,750 | +2.9% | 0.00% | 0.0% |
| Q3 2021 | $1,010,000 | +6.8% | 8,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $946,000 | -4.7% | 8,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $993,000 | +14.5% | 8,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $867,000 | +23.3% | 8,500 | -4.5% | 0.00% | 0.0% |
| Q3 2020 | $703,000 | – | 8,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 47,376 | $8,605,377 | 3.04% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |